Postpartum inhibitor to factor VIII: Treatment with high-dose immunoglobulin and dexamethasone

Haemophilia

Volumn 7, Issue 4, 2001, Pages 422-427

  Mazzucconi, M G ^a,b,c   Bizzoni, L ^a,b   Giorgi, A ^a,b   Morano, S G ^a,b   Peraino, M ^a,b   Russo, M ^a,b   Alimena, G ^a,b  

^a Dipartimento di Biotecnologie Cellulari ed Ematologia   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NONE   (Italy)

Author keywords

Acquired inhibitor to coagulation factors; Dexamethasone; Factor VIII; High dose immunoglobulin; Immunosuppressive therapy

Indexed keywords

AZATHIOPRINE; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DESMOPRESSIN; DEXAMETHASONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLEEDING DISORDER; BLOOD CLOTTING; CASE REPORT; CHILDBIRTH; CONTROLLED STUDY; DRUG MEGADOSE; DRUG SAFETY; ERADICATION THERAPY; FEMALE; HUMAN; IDIOPATHIC DISEASE; PRIORITY JOURNAL; PUERPERIUM; REMISSION; SYMPTOM; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES; DEXAMETHASONE; FACTOR VIII; FEMALE; HUMANS; IMMUNOGLOBULINS; POSTPARTUM PERIOD;

EID: 0034916854     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2001.00529.x     Document Type: Article

References (18)

1. A survey of 215 non-haemophilic patients with inhibitors to factor VIII
2. Post-partum factor VIII inhibitors
3. Acquired hemophilia due to factor VIII inhibitors in 34 patients
4. A prospective randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII antibodies
5. Successful treatment of acquired hemophilia with oral immunosuppressive therapy
6. Antiidiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin
7. Intravenous immunoglobulin in the treatment of spontaneously acquired factor VIII:C inhibitors
8. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin
9. Low response to high-dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor
10. The Nijmegen modification of the Bethesda assay for factor VIII. C inhibitors: Improved specificity and reliability
11. Immunosuppression of factor VIII inhibitors in non hemophilic patients
12. Treatment of factor VIII inhibitors
13. The treatment of factor VIII inhibitors: A general overview
14. The use of porcine factor VIII concentrate (Hyate: C) in the treatment of patients with antibodies to factor VIII:C. A Multicenter U S Trial
15. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: A multicentre study
16. The effect of 1-deamino-8-D-arginine vasopressin (DDAVP) in a nonhaemophilic patient with an acquired type II factor VIII inhibitor
17. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy
18. Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisone